-
-
-
-
-
-
-
TD Cowen on Prime Medicine (PRME): 'We continue to view PRME as undervalued for the platform’s potential'
-
-
-
-
-
-
-
Prime Medicine, Inc. (PRME) Tops Q1 EPS by 8c
-
-
-
-
-
-
-
Prime Medicine names Matthew Hawryluk as chief business officer
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Prime Medicine (PRME)
-
-
-
-
-
-
-
Citi on Prime Medicine (PRME) with shares down 20pct: 'Initial Human Data from a Prime Editing Therapy Show Promise, but Financing Risk Remains a Key Overhang'
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Prime Medicine (PRME)
-
-
-
-
-
-
-
BMO Capital Reiterates Outperform Rating on Prime Medicine (PRME)
-
473,224 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


